Immunoliposomes for Cardiovascular Targeting

Levchenko, Tatyana; Hartner, William C.; Torchilin, Vladimir P.

doi:10.1002/9781118229019.ch2

Cited by 1 publication

(2 citation statements)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…multifunctional dendrimers, liposomes, or nanoparticles. One of the most effective transporters is the multifunctional drug delivery liposome with CPPs at the surface, developed by Torchilin [25,[136][137][138][139][140].…”

Section: Multifunctional Drug Delivery Complexesmentioning

confidence: 99%

“…Doxorubicin , small interfering RNA (siRNA) , and DNA are transported as cargos and used to treat for instance nonsmall‐cell lung cancer . The delivery was mediated by HIV‐TAT sequences on the surface of these nanocarriers or by selective antitumor antibodies on the surface of immunoliposomes . The group of Neundorf treated successfully cancer tissue with metallorganic compounds coupled to suitable CPPs and even an ACPP .…”

Section: Cell and Tissue Selectivity Of Cppsmentioning

confidence: 99%

See 1 more Smart Citation

Cell penetration: scope and limitations by the application of cell-penetrating peptides

2014

View full text Add to dashboard Cite

The penetration of polar or badly soluble compounds through a cell membrane into live cells requires mechanical support or chemical helpers. Cell-penetrating peptides (CPPs) are very promising chemical helpers. Because of their low cytotoxicity and final degradation to amino acids, they are particularly favored in in vivo studies and for clinical applications. Clearly, the future of CPP research is bright; however, the required optimization studies for each drug require considerable individualized attention. Thus, CPPs are not the philosopher's stone. As of today, a large number of such transporter peptides with very different sequences have been identified. These have different uptake mechanisms and can transport different cargos. Intracellular concentrations of cargos can reach a low micromole range and are able to influence intracellular reactions. Internalized ribonucleic acids such as small interfering RNA (siRNA) and mimics of RNA such as peptide nucleic acids, morpholino nucleic acids, and triesters of oligonucleotides can influence transcription and translation. Despite the highly efficient internalization of antibodies, enzymes, and other protein factors, as well as siRNA and RNA mimics, the uptake and stabile insertion of DNA into the genome of the host cells remain substantially challenging. This review describes a wide array of differing CPPs, cargos, cell lines, and tissues. The application of CPPs is compared with electroporation, magnetofection, lipofection, viral vectors, dendrimers, and nanoparticles, including commercially available products. The limitations of CPPs include low cell and tissue selectivity of the first generation and the necessity for formation of fusion proteins, conjugates, or noncovalent complexes to different cargos and of cargo release from intracellular vesicles. Furthermore, the noncovalent complexes require a strong molar excess of CPPs, and extensive experimentation is required to determine the most optimal CPP for any given cargo and cell type. Yet to predict which CPP is optimal for any given target remains a complex question. More recently, there have been promising developments: the enhancement of cell specificity using activatable CPPs, specific transport into cell organelles by insertion of corresponding localization sequences, and the transport of drugs through blood-brain barriers, through the conjunctiva of eyes, skin, and into nerve cells. Proteins, siRNA, and mimics of oligonucleotides can be efficiently transported into cells and have been tested for treatment of certain diseases. The recent state of the art in CPP research is discussed together with the overall scope, limitations, and some recommendations for future research directions.

show abstract